For patients with atopic asthma, the immune system’s abnormal reaction to allergens is a major cause of asthma symptoms. Allergen avoidance is a first natural step to tackle asthma.
On-going clinical trials
The LASER Trial – A UK trial is assessing whether Temperature-controlled Laminar Airflow, Airsonett, can reduce the frequency of asthma attacks and improve quality of life in patients with severe allergic asthma. The LASER Trial is funded by the National Institute for Health Research Health Technology Assessment Programme (Project number 12/33/28). Now recruiting patients at sites across the UK. Find out more
Airsonett is a treatment for patients with severe atopic asthma who, in spite of taking asthma medication, still has poorly controlled asthma.
Airsonett ensures that the patient sleeps in clean air. Studies show that Airsonett inhibits the allergy, reduces the inflammation and improves quality of life.
Airsonett expands its organization (2014-12-05)